Publicador de continguts

Eliminació de la malària

Mechanistic aspects of P. vivax

Mechanistic aspects of anemia and splenomegaly caused by plasmodium vivax, a neglected human parasite

Foto: C. Fernandez and H. del Portillo
Durada
01/01/2017-31/12/2019
Coordinador
Carmen Fernández Becerra/ Hernando A. Del Portillo
Finançadors
MINECO
Pàgina web
http://www.pvrex.com/

Despite the high burden exerted, Plasmodium vivax has been a ‘neglected’ human malaria parasite. In the last decade, anaemia is one the most prevalent severe malaria manifestations worldwide. Recently, we have obtained first unequivocal evidence of the presence of P. vivax parasites in the bone marrow of an infected patient. Moreover, transcriptional analysis of bone marrow aspirates during infection and at convalescence of this same patient demonstrated transcriptional changes of miRNAs related to erythropoiesis. Also, it is known that P. vivax infections cause bone marrow dyserythropoiesis and ineffective erythropoiesis.

Anaemia in malaria is further exacerbated through the destruction of uninfected red blood cells. Destruction of red blood cells is a function of the spleen, our only blood filtering organ. Splenomegaly is a hallmark of human malarial infections and the degree of anaemia is related to the size of the spleen. Moreover, it has been established that in benign red blood cell disorders inducing anaemia, there is extramedullary haematopoiesis in this organ to compensate for the lack of red blood cells.

Through this proposal our aim is to demonstrate:

(i) that P. vivax invades the bone marrow and causes dyserythropiesis and ineffective erythropoiesis through transcriptional changes;

(ii) that to compensate for this anaemia, bone-marrow derived exosomes from infections signals spleen reticular cells to create hematopoietic niches facilitating extramedullary haematopoiesis in this organ.

Total funding

205,700.00 €

Our Team

Principal Investigator

  • Hernando Del Portillo Obando
    Hernando Del Portillo Obando
  • Maria Carmen Fernandez Becerra
    Maria Carmen Fernandez Becerra

ISGlobal team

Altres projectes

Veure projectes passats

MESA

L'Aliança Científica per a l'Eradicació de la Malària (MESA) té com a objectiu avançar en la ciència de l'eradicació de la malària.

NHEPACHA

Noves Eines per al Diagnòstic i l'Avaluació del Pacient amb Malaltia de Chagas

RTS,S Vaccine Immunology Study

Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial

Euroleish.net

Control of Leishmaniasis. From bench to bedside and community

GREPIMER

Grup de recerca en patología importada i malaties emergents i re-emergents

TESEO

Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

ADAM

Administración masiva y focal de fármacos antimaláricos para avanzar hacia la eliminación de la malaria en Mozambique: acelerando la implementación de programas y políticas

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

Science4Pandemics

Citizens engagement digital platform for collective intelligence in pandemics

HIDDENVIVAX

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

MENA Migrant Health

Transforming data collection and surveillance to drive migrant health research, care and policy

SexMal

Social affairs and sex in P. falciparum: implications for malaria elimination

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

SMART

Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test

MalTransc

Transcriptional regulation of adaptation and developmental decisions in malaria parasites: from epigenetic variation to directed transcriptional responses

GenMoz

P. falciparum genomic intelligence in Mozambique

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa